Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ur-1102
1. 1198153-15-9
2. Ur-1102
3. 0yp1me85gh
4. (3,5-dibromo-4-hydroxyphenyl)(2,3-dihydro-4h-pyrido(4,3-b)-1,4-oxazin-4-yl)methanone
5. Methanone, (3,5-dibromo-4-hydroxyphenyl)(2,3-dihydro-4h-pyrido(4,3-b)-1,4-oxazin-4-yl)-
6. (3,5-dibromo-4-hydroxyphenyl)(2,3-dihydro-4h-pyrido[4,3-b]-1,4-oxazin-4-yl)methanone
7. Epaminuradum
8. Refchem:137079
9. Ur 1102
10. Epaminurad [inn]
11. Unii-0yp1me85gh
12. Chembl4640580
13. (3,5-dibromo-4-hydroxyphenyl)(2,3-dihydro-4h-pyrido[4,3-b][1,4]oxazin-4-yl)methanone
14. (3,5-dibromo-4-hydroxyphenyl)-(2,3-dihydropyrido[4,3-b][1,4]oxazin-4-yl)methanone
15. C14h10br2n2o3
16. Orb1700643
17. Schembl1191165
18. Dtxsid901385228
19. Glxc-15814
20. Ex-a4697
21. Yxb15315
22. Bdbm50538736
23. Mfcd28978060
24. Akos040748326
25. Da-68490
26. Ms-27164
27. Hy-111345
28. Cs-0035278
29. (3,5-dibromo-4-hydroxy-phenyl)-(2,3-dihydro-pyrido[4,3-b][1,4]oxazin-4-yl)-methanone
30. (3,5-dibromo-4-hydroxy-phenyl)-(2,3-dihydropyrido[4,3-b][1,4]oxazin-4-yl)methanone
31. (3,5-dibromo-4-hydroxyphenyl)(2h-pyrido[4,3-b][1,4]oxazin-4(3h)-yl)methanone
| Molecular Weight | 414.05 g/mol |
|---|---|
| Molecular Formula | C14H10Br2N2O3 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 62.7 |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 386 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
99
PharmaCompass offers a list of Epaminurad API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Epaminurad manufacturer or Epaminurad supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Epaminurad manufacturer or Epaminurad supplier.
A Epaminurad manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Epaminurad, including repackagers and relabelers. The FDA regulates Epaminurad manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Epaminurad API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Epaminurad supplier is an individual or a company that provides Epaminurad active pharmaceutical ingredient (API) or Epaminurad finished formulations upon request. The Epaminurad suppliers may include Epaminurad API manufacturers, exporters, distributors and traders.
Epaminurad Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Epaminurad GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Epaminurad GMP manufacturer or Epaminurad GMP API supplier for your needs.
A Epaminurad CoA (Certificate of Analysis) is a formal document that attests to Epaminurad's compliance with Epaminurad specifications and serves as a tool for batch-level quality control.
Epaminurad CoA mostly includes findings from lab analyses of a specific batch. For each Epaminurad CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Epaminurad may be tested according to a variety of international standards, such as European Pharmacopoeia (Epaminurad EP), Epaminurad JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Epaminurad USP).
